| Old Articles: <Older 8941-8950 Newer> |
|---|
 |
Chemistry World
September 25, 2014
Hepeng Jia |
GSK fined 300 million for China corruption After investigation by Chinese police, the British pharmaceutical giant GlaxoSmithKline was fined a record Yuan3 billion ( 300 million pounds) for bribing Chinese doctors and hospital officials.   |
Chemistry World
September 24, 2014
Phillip Broadwith |
Review says cheaper drug is safe for eye disease Researchers have added weight to the argument that health services should use the cancer drug Avastin (bevacizumab) to treat age-related wet macular degeneration, instead of the more expensive Lucentis (ranibizumab). |
Chemistry World
September 23, 2014
Phillip Broadwith |
Gilead licenses generic hepatitis C drug in India Gilead has granted licenses to seven generic drugmakers to produce its blockbuster hepatitis C drug Sovaldi (sofosbuvir) in India and 90 other developing nations. |
Chemistry World
September 18, 2014
Tim Wogan |
Painkiller found in plants may not be natural after all In 2013 the surprising discovery was made that the opioid painkiller tramadol, thought to be synthetic, was being produced by the African herb Nauclea latifolia. However, new research casts doubt on this claim. |
Chemistry World
September 16, 2014
James Urquhart |
Blaze destroys Nottingham sustainable chemistry lab The GlaxoSmithKline Carbon Neutral Laboratory for Sustainable Chemistry at the University of Nottingham's jubilee campus, was under construction and slated to be finished by mid-2015. |
Chemistry World
September 11, 2014
Emma Stoye |
Pharma sales 'will reach $1 trillion' in 2014 Global sales in the pharmaceutical industry are set to go over the $1 trillion mark this year, according to a report by Thomson Reuters. |
Chemistry World
September 10, 2014
Emma Stoye |
Cipla targets asthma market with Advair copy Indian pharma company Cipla has begun selling a generic version of GlaxoSmithKline's combination asthma treatment Advair (fluticasone/salmeterol) in Germany and Sweden. |
Pharmaceutical Executive
September 1, 2014
Richard Koonce |
Executive Coaching: Transforming Big Pharma from Within Let's define the critical coaching steps necessary for top managers to realize their potential in an industry undergoing significant restructuring of human and financial capital. |
Pharmaceutical Executive
September 1, 2014
Bill Trombetta |
13th Annual Industry Audit After a dip into negative territory in 2012, 2013 delivered a resurgence in sales revenues, but the turnaround only spotlights a larger trend: the growing divide between the big Pharmas and the more nimble players. |
Pharmaceutical Executive
September 1, 2014
William Looney |
Ireland's Celtic Tiger: Back on the Hunt Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products. |
| <Older 8941-8950 Newer> Return to current articles. |
